Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.
Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.3.4 instead of v3.3.3; this update does not modify study details, eligibility criteria, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedLocations section updated with a revised list of study sites, including additions and removals across the United States and international regions.SummaryDifference2%
- Check57 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2.SummaryDifference0.5%
- Check64 days agoChange DetectedStandardized the Taiwan site name by replacing 'Tainan City, Taiwan' with 'Tainan, Taiwan' in the locations section.SummaryDifference0.3%
- Check78 days agoChange DetectedMinor UI updates and timestamp changes observed; core study details remain unchanged, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check107 days agoChange DetectedAdded a government funding notice and a v3.2.0 revision tag; removed the previous v3.1.0 tag. If any time-sensitive content (operating status) is now present, it should be considered updated.SummaryDifference3%
Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.